PropertyValue
?:abstract
  • The severity of coronavirus disease 2019 (COVID-19) symptoms and outcomes vary immensely among patients Predicting disease progression and managing disease symptoms is even more challenging in cancer patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Cancer therapies, including chemotherapy, radiotherapy, and immunotherapy, often suppress the immune system, rendering cancer patients more susceptible to SARS-CoV-2 infection and the development of severe complications However, data on the effects of immunosuppression on COVID-19 outcomes in cancer patients remain limited Further investigations are warranted to better understand the implications of SARS-CoV-2 infection in cancer patients, particularly those that are immunocompromised In this review, we outline the current knowledge of the effects of SARS-CoV-2 infection in cancer patients
is ?:annotates of
?:creator
?:journal
  • Cancers
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis
?:type
?:who_covidence_id
  • #909236
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/8k51es84>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/8k51es84>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all